Prognostic and predictive significance of altered microRNA expression in pancreatic cancer
Eurasian Journal of Medicine and Oncology · 2025-10-08 · 10 (5) · 025200190
DOI: 10.36922/ejmo025200190 ↗Abstract
Introduction: Pancreatic cancer (PC) remains one of the most lethal malignancies with a dismal 5-year survival rate of 13%. MicroRNAs (miRNAs) have emerged as critical regulators in tumor progression, yet their clinical relevance in PC requires validation through large-scale datasets. Objective: This study aims to detect irregularities in miRNA expression within PC patients by analyzing data sourced from the Cancer Genome Atlas (TCGA) database. Methods: Expression profiles of 14 miRNAs in 183 PC patients were analyzed using data from the TCGA database, correlating them with survival, tumor-node-metastasis stage, tumor grade, recurrence, and lymph node metastasis. Molecular mechanisms were explored via target prediction and correlation analysis. Results: Reduced miR-107 expression and elevated miR-21 expression were each independently linked to worse overall survival (p
EUVIMED